Lamia Bouazza
Overview
Explore the profile of Lamia Bouazza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Mauro P, Croset M, Bouazza L, Clezardin P, Reynaud C
J Bone Oncol
. 2024 Jan;
44:100522.
PMID: 38283827
The primary function of the lysyl oxidase (LOX) family, including LOX and its paralogue LOX-like (LOXL)-2, is to catalyze the covalent crosslinking of collagen and elastin in the extracellular matrix....
2.
Saier L, Ribeiro J, Daunizeau T, Houssin A, Ichim G, Barette C, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293074
Metastases are the main cause of death in cancer patients, and platelets are largely known for their contribution in cancer progression. However, targeting platelets is highly challenging given their paramount...
3.
Xu H, Lafage-Proust M, Bouazza L, Geraci S, Clezardin P, Roche B, et al.
Cancers (Basel)
. 2022 Jul;
14(14).
PMID: 35884504
Bone metastases are frequent complications of breast cancer, facilitating the development of anarchic vascularization and induce bone destruction. Therefore, anti-angiogenic drugs (AAD) have been tested as a therapeutic strategy for...
4.
Bouchet M, Laine A, Boyault C, Proponnet-Guerault M, Meugnier E, Bouazza L, et al.
Cancer Res
. 2020 May;
80(13):2914-2926.
PMID: 32366476
Bone is the most common metastatic site for breast cancer. Although the estrogen-related receptor alpha (ERRα) has been implicated in breast cancer cell dissemination to the bone from the primary...
5.
Vollaire J, Machuca-Gayet I, Lavaud J, Bellanger A, Bouazza L, El Moghrabi S, et al.
Front Pharmacol
. 2019 Jul;
10:667.
PMID: 31275146
Breast cancer with bone metastasis is essentially incurable with current anticancer therapies. The bone morphogenetic protein (BMP) pathway is an attractive therapeutic candidate, as it is involved in the bone...
6.
Fradet A, Bouchet M, Delliaux C, Gervais M, Kan C, Benetollo C, et al.
Oncotarget
. 2016 Oct;
7(47):77071-77086.
PMID: 27776343
Bone metastases are one of the main complications of prostate cancer and they are incurable. We investigated whether and how estrogen receptor-related receptor alpha (ERRα) is involved in bone tumor...
7.
Selmi-Ruby S, Bouazza L, Obregon M, Conscience A, Flamant F, Samarut J, et al.
Endocrinology
. 2013 Nov;
155(2):635-46.
PMID: 24265449
Thyroid epithelial cells, or thyrocytes, express functional thyroid hormone receptors but no precise role has yet been assigned to either TRα or TRβ in the thyroid gland. In this study,...
8.
Fradet A, Sorel H, Bouazza L, Goehrig D, Depalle B, Bellahcene A, et al.
Cancer Res
. 2011 Jul;
71(17):5728-38.
PMID: 21734015
Bone metastasis is a complication occurring in up to 70% of advanced breast cancer patients. The estrogen receptor-related receptor alpha (ERRα) has been implicated in breast cancer and bone development,...
9.
Langlois D, Hneino M, Bouazza L, Parlakian A, Sasaki T, Bricca G, et al.
Transgenic Res
. 2010 Mar;
19(6):1069-82.
PMID: 20213136
To understand the role of TGF-β signaling in cardiovascular development, we generated mice with conditional deletion of the TGF-β type II receptor (TβRII) gene (Tgfbr2) in cells expressing the smooth...
10.
Hneino M, Bouazza L, Bricca G, Li J, Langlois D
J Vasc Res
. 2008 Jul;
46(2):85-97.
PMID: 18596377
Background: TGF-beta shifts from inhibition to stimulation of vascular smooth muscle cell (vSMC) growth when cell density increases. How proliferation and apoptosis contribute to this shift is still unknown. Methods:...